Literature DB >> 11577789

Sensitizing clinicians and patients to the social and functional aspects of remission.

M H Trivedi1.   

Abstract

Axis I disorders are defined by specific symptom constellations that are frequently accompanied by notable impairments in social functioning. Social role impairments diminish personal fulfillment, satisfaction, and quality of life. It is now clear that these findings suggest a broader definition of remission that involves not only the absence of symptoms but also improvement in psychosocial functioning. Clinicians and patients need to become sensitized to the role of social functioning and quality of life in the assessment of treatment outcomes. Although there has been a recent emphasis on the inclusion of social function and quality of life measures in the definition of and requirements for remission, numerous standardized scales for measuring these factors already exist. In addition, selection of efficacious therapeutic agents proven to promote both elimination of symptoms and return to full social functioning is important. Finally, significant improvement in both symptoms and function may be necessary to prevent not only relapse but also ensure full remission of anxiety and depressive disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11577789

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  4 in total

1.  Role stress, role reward, and mental health in a multiethnic sample of midlife women: results from the Study of Women's Health Across the Nation (SWAN).

Authors:  Teresa Lanza di Scalea; Karen A Matthews; Nancy E Avis; Rebecca C Thurston; Charlotte Brown; Sioban Harlow; Joyce T Bromberger
Journal:  J Womens Health (Larchmt)       Date:  2012-02-23       Impact factor: 2.681

2.  Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release.

Authors:  Madhukar H Trivedi; David L Dunner; Susan G Kornstein; Michael E Thase; John M Zajecka; Anthony J Rothschild; Edward S Friedman; Richard C Shelton; Martin B Keller; James H Kocsis; Alan Gelenberg
Journal:  J Affect Disord       Date:  2010-05-26       Impact factor: 4.839

3.  Psychosocial functioning in patients with Treatment-Resistant Depression after group cognitive behavioral therapy.

Authors:  Miki Matsunaga; Yasumasa Okamoto; Shin-ichi Suzuki; Akiko Kinoshita; Shinpei Yoshimura; Atsuo Yoshino; Yoshihiko Kunisato; Shigeto Yamawaki
Journal:  BMC Psychiatry       Date:  2010-03-16       Impact factor: 3.630

4.  The relationship of health-related quality of life and treatment outcome during inpatient treatment of depression.

Authors:  Stephan Köhler; Theresa Unger; Sabine Hoffmann; Arthur Mackert; Barbara Ross; Thomas Fydrich
Journal:  Qual Life Res       Date:  2014-09-21       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.